Confluence Wealth Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
11,162
+7,986
+251% +$1.05M 0.04% 192
2026
Q1
$443K Hold
3,176
0.02% 277
2025
Q4
$390K Sell
3,176
-481
-13% -$58.5K 0.02% 286
2025
Q3
$406K Sell
3,657
-834
-19% -$94.8K 0.02% 278
2025
Q2
$498K Sell
4,491
-586
-12% -$62.4K 0.03% 243
2025
Q1
$540K Sell
5,077
-387
-7% -$39.9K 0.03% 223
2024
Q4
$508K Sell
5,464
-8,871
-62% -$799K 0.03% 217
2024
Q3
$1.2M Sell
14,335
-572
-4% -$43.6K 0.09% 122
2024
Q2
$1.02M Buy
14,907
+4,210
+39% +$281K 0.08% 142
2024
Q1
$784K Buy
10,697
+2,500
+30% +$192K 0.07% 160
2023
Q4
$664K Buy
8,197
+1,179
+17% +$91.7K 0.07% 157
2023
Q3
$526K Buy
7,018
+1,247
+22% +$95.9K 0.1% 152
2023
Q2
$445K Buy
5,771
+2,177
+61% +$174K 0.09% 167
2023
Q1
$298K Buy
+3,594
New +$298K 0.07% 194
2022
Q1
Sell
-284
Closed -$20K 594
2021
Q4
$20K Buy
+284
New +$19.6K 0.01% 727

Other funds holding GILD

Confluence Wealth Services's GILD Position: Q2 2026 in Review

Confluence Wealth Services increased its Gilead Sciences (GILD) stake by 251% in Q2 2026, buying an estimated $1.05M and bringing the position to 11,162 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #192.

Confluence Wealth Services first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Confluence Wealth Services held 11,162 shares of Gilead Sciences worth $1.41M as of Q2 2026.
  • Confluence Wealth Services bought 7,986 Gilead Sciences shares in Q2 2026, an estimated $1.05M.
  • Gilead Sciences made up 0.04% of Confluence Wealth Services's portfolio in Q2 2026, its #192 holding.
  • Confluence Wealth Services first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.